These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 1068340)
1. L-asparaginase reinduction and maintenance therapy in previously treated acute lymphocytic leukemia. Sieger L; Higgins G; Ortega J; Shore N; Williams K Med Pediatr Oncol; 1976; 2(3):327-32. PubMed ID: 1068340 [TBL] [Abstract][Full Text] [Related]
2. L-Asparaginase as a single agent in acute lymphocytic leukemia: survey of studies form Childrens Cancer Study Group. Nesbit ME; Ertel I; Hammond GD Cancer Treat Rep; 1981; 65 Suppl 4():101-7. PubMed ID: 7049373 [TBL] [Abstract][Full Text] [Related]
3. L-Asparaginase, vincristine, and prednisone for induction of first remission in acute lymphocytic leukemia. Ortega JA; Nesbit ME; Donaldson MH; Hittle RE; Weiner J; Karon M; Hammond D Cancer Res; 1977 Feb; 37(2):535-40. PubMed ID: 264412 [TBL] [Abstract][Full Text] [Related]
4. Effective dose of L-asparaginase for induction of remission in previously treated children with acute lymphocytic leukemia: a report from Childrens Cancer Study Group. Ertel IJ; Nesbit ME; Hammond D; Weiner J; Sather H Cancer Res; 1979 Oct; 39(10):3893-6. PubMed ID: 383278 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of intramuscular versus intravenous administration of L-asparaginase in childhood leukemia. Nesbit M; Chard R; Evans A; Karon M; Hammond GD Am J Pediatr Hematol Oncol; 1979; 1(1):9-13. PubMed ID: 295576 [TBL] [Abstract][Full Text] [Related]
6. Treatment of acute lymphoblastic leukemia in relapse: efficacy of a four-drug reinduction regimen. Poplack DG; Reaman GH; Wesley R Cancer Treat Rep; 1981; 65 Suppl 4():93-6. PubMed ID: 6955015 [TBL] [Abstract][Full Text] [Related]
7. Combination chemotherapy for children with acute lymphocytic leukemia who fail to respond to standard remission-induction therapy. Lay HN; Ekert H; Colebatch JH Cancer; 1975 Oct; 36(4):1220-2. PubMed ID: 1058044 [TBL] [Abstract][Full Text] [Related]
8. L-asparaginase used with cytosine arabinoside in treatment of childhood acute lymphocytic leukemia refractory to vincristine and prednisone. Smithson WA; Gilchrist GS; Burgert EO Med Pediatr Oncol; 1979; 6(2):163-70. PubMed ID: 287856 [TBL] [Abstract][Full Text] [Related]
9. Sequential combination of methotrexate and L-asparaginase in the treatment of refractory acute leukemia. Amadori S; Tribalto M; Pacilli L; De Laurentis C; Papa G; Mandelli F Cancer Treat Rep; 1980; 64(8-9):939-42. PubMed ID: 6934851 [TBL] [Abstract][Full Text] [Related]
10. Optimal use of L-asparaginase (NSC-109229) in acute lymphocytic leukemia. Jones B; Holland JF; Glidewell O; Jacquillat C; Weil M; Pochedly C; Sinks L; Chevalier L; Maurer HM; Koch K; Falkson G; Patterson R; Seligman B; Sartorius J; Kung F; Haurani F; Stuart M; Burgert EO; Ruymann F; Sawitsky A; Forman E; Pluess H; Truman J; Hakami N Med Pediatr Oncol; 1977; 3(4):387-400. PubMed ID: 337095 [No Abstract] [Full Text] [Related]
11. [L-asparaginase in combined treatment of acute leukemia not affecting the bone marrow]. Cyklis R; Armata J; Legutko L Acta Haematol Pol; 1974; 5(3):201-6. PubMed ID: 4528224 [No Abstract] [Full Text] [Related]
12. Comparison of the therapeutic response of patients with childhood acute lymphoblastic leukemia in relapse to vindesine versus vincristine in combination with prednisone and L-asparaginase: a phase III trial. Anderson J; Krivit W; Chilcote R; Pyesmany A; Chard R; Hammond D Cancer Treat Rep; 1981; 65(11-12):1015-9. PubMed ID: 6945911 [TBL] [Abstract][Full Text] [Related]
13. E. coli L-asparaginase in the treatment of leukemia and solid tumors in 131 children. Tallal L; Tan C; Oettgen H; Wollner N; McCarthy M; Helson L; Burchenal J; Karnofsky D; Murphy ML Cancer; 1970 Feb; 25(2):306-20. PubMed ID: 4905155 [No Abstract] [Full Text] [Related]
14. Asparaginase in combination chemotherapy for remission induction of childhood acute lymphocytic leukemia. Pratt CB; Roberts D; Shanks E; Warmath EL; Jackson R Cancer Res; 1973 Sep; 33(9):2020-5. PubMed ID: 4516498 [No Abstract] [Full Text] [Related]
15. Reduced antithrombin III levels during L-asparaginase therapy. Buchanan GR; Holtkamp CA Med Pediatr Oncol; 1980; 8(1):7-14. PubMed ID: 6934369 [TBL] [Abstract][Full Text] [Related]
17. Comparison of daily and twice-weekly schedule of L-asparaginase in childhood leukemia. Jaffe N; Traggis D; Das L; Kim BS; Won H; Hann L; Moloney WC; Dohlwitz A Pediatrics; 1972 Apr; 49(4):590-5. PubMed ID: 4501679 [No Abstract] [Full Text] [Related]
18. Combination chemotherapy for bone marrow relapse in childhood lymphoblastic leukaemia (ALL). Chessells JM; Cornbleet M Med Pediatr Oncol; 1979; 6(4):359-65. PubMed ID: 289904 [TBL] [Abstract][Full Text] [Related]
19. Effect of protracted high-dose L-asparaginase given as a second exposure in a Berlin-Frankfurt-Münster-based treatment: results of the randomized 9102 intermediate-risk childhood acute lymphoblastic leukemia study--a report from the Associazione Italiana Ematologia Oncologia Pediatrica. Rizzari C; Valsecchi MG; Aricò M; Conter V; Testi A; Barisone E; Casale F; Lo Nigro L; Rondelli R; Basso G; Santoro N; Masera G; J Clin Oncol; 2001 Mar; 19(5):1297-303. PubMed ID: 11230471 [TBL] [Abstract][Full Text] [Related]
20. [Repeated treatment with L-asparaginase of acute lymphoblastic leukemia in children]. Zajaczkowski J; Depowska T; Legutko L; Armata J Pol Tyg Lek; 1974 Aug; 29(32):1381-3. PubMed ID: 4527522 [No Abstract] [Full Text] [Related] [Next] [New Search]